Patent details
EP3510023 Title: CRYSTALLINE FORMS OF A LYSYL OXIDASE-LIKE 2 INHIBITOR AND METHODS OF MAKING
Basic Information
- Publication number:
- EP3510023
- PCT Application Number:
- US2017050332
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP178494795
- PCT Publication Number:
- WO2018048943
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRYSTALLINE FORMS OF A LYSYL OXIDASE-LIKE 2 INHIBITOR AND METHODS OF MAKING
- French Title of Invention:
- FORMES CRISTALLINES D'UN INHIBITEUR DE LYSYL OXYDASE DE TYPE 2 ET LEURS PROCÉDÉS DE FABRICATION
- German Title of Invention:
- KRISTALLINE FORMEN EINES LYSYLOXIDASE-LIKE-2-INHIBITORS UND VERFAHREN ZUR HERSTELLUNG
- SPC Number:
Dates
- Filing date:
- 06/09/2017
- Grant date:
- 19/06/2024
- EP Publication Date:
- 17/07/2019
- PCT Publication Date:
- 15/03/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 19/06/2024
- EP B1 Publication Date:
- 19/06/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 06/09/2024
- Expiration date:
- 06/09/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 12/06/2024
- Name:
- Pharmakea, Inc.
- Address:
- 3030 Bunker Hill Street Suite 300, San Diego, California 92109, United States (US)
Inventor
1
- Name:
- HOLME, Kevin Ross
- Address:
- United States (US)
2
- Name:
- LONERGAN, David
- Address:
- United States (US)
3
- Name:
- ROWBOTTOM, Martin W.
- Address:
- United States (US)
Priority
- Priority Number:
- 201662384596 P
- Priority Date:
- 07/09/2016
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07D 401/12; C07D 207/12; C07C 309/66; A61K 31/4439; A61P 35/00; A61P 43/00;
Publication
European Patent Bulletin
- Issue number:
- 202425
- Publication date:
- 19/06/2024
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|